Related Experiment Video

Updated: May 30, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in

Emil Scosyrev, Edward M Messing

    BJU International
    |August 23, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Related Experiment Videos

    Last Updated: May 30, 2026

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Pooled Analysis of REMIX-1 and REMIX-2 Trials.

    The journal of allergy and clinical immunology. In practice·2026

    Iptacopan in IgA Nephropathy - Final 24-Month Data.

    The New England journal of medicine·2026

    Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria.

    CPT: pharmacometrics & systems pharmacology·2025

    Implementation challenges of single-instillation intravesical chemotherapy following transurethral resection of bladder tumor.

    Expert review of anticancer therapy·2025

    Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder.

    Oncogene·2025

    Disproportionality Analysis and Causal Inference in Drug Safety.

    Pharmaceutical medicine·2025

    Endoscopic kidney-sparing surgery for upper tract urothelial carcinoma in patients with a solitary kidney.

    BJU international·2026

    EXPRESSION OF CONCERN: Small Interference RNA Targeting Heat-Shock Protein 27 Inhibits the Growth of Prostatic Cell Lines and Induces Apoptosis via Caspase-3 Activation In Vitro.

    BJU international·2026

    Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0.

    BJU international·2026

    Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.

    BJU international·2026

    First-in-human outpatient management of recurrent NMIBC with the Multi4 instrument.

    BJU international·2026

    Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC.

    BJU international·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us